Lansoprazole and Sodium Bicarbonate Capsules(Beijing Xuze Pharma)

兰索拉唑碳酸氢钠胶囊（北京旭泽医药）

Report date: 2025/08/26 11:37:51

Base Information

Drug NameLansoprazole and Sodium Bicarbonate Capsules(Beijing Xuze Pharma)
Drug Alias Name兰索拉唑碳酸氢钠胶囊（2.2类改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsUlcerStomach UlcerDuodenal Ulcer +[5] 
Global Approved IndicationsUlcerStomach UlcerDuodenal Ulcer +[5] 
Approved Indications in ChinaUlcerStomach UlcerDuodenal Ulcer +[5] 
Original Approved Country/TerritoryMainland China
Original Approved Date2022/09/30
Country/TerritoryMainland China
CombinationsYes LansoprazoleSodium Bicarbonate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Xuze Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Xuze Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsUlcerStomach UlcerDuodenal Ulcer +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A